Evidence map›Paper›PMID 23208218›Full record

ArticleJournal of biomedical optics2012

Measuring incidence angle for through-the-objective total internal reflection fluorescence microscopy.

Thomas P Burghardt

Abstract read
In one paragraph

Article in Journal of biomedical optics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Thomas P BurghardtMayo Clinic Rochester, Department of Biochemistry and Molecular Biology, Rochester, Minnesota 55905, USA. burghardt@mayo.edu

Funding

Visualizing Actomyosin Transients by Data MergingR01AR049277 · NIAMS · MAYO CLINIC ROCHESTER · PI BURGHARDT, THOMAS P · 2004 to 2013
$3.2M
In Situ Sensing of Single Myosin Function in Hypertrophy DiseaseR01HL095572 · NHLBI · MAYO CLINIC ROCHESTER · PI BURGHARDT, THOMAS P · 2010 to 2013
$1.5M
NHLBI NIH HHS R01 HL095572NHLBI NIH HHS R01HL095572NIAMS NIH HHS R01 AR049277NIAMS NIH HHS R01AR049277
6 · The paper itself

Abstract

Total internal reflection fluorescence (TIRF) microscopy has the exciting laser beam incident beyond critical angle from the glass side of a glass/aqueous interface formed by the coverslip and aqueous sample. The aqueous side evanescent field decays exponentially with distance from the interface with penetration depth depending on incidence angle. Through-the-objective TIRF has the exciting laser focused at the back focal plane (BFP) creating a refracted parallel beam approaching the interface in the small gap between objective and coverslip, making incidence angle challenging to measure. Objective axial scanning does not affect incidence angle but translates beam and interface intersection detected by the fluorescence center of mass from fluorescent spheres attached to the aqueous side of the interface. Center of mass translation divided by the axial translation is the tangent of the incidence angle that is sampled repeatedly over objective trajectory to obtain a best estimate. Incidence angle is measured for progressively larger radial positions of the focused beam on the BFP. A through-the-objective TIRF microscope, utilizing a micrometer and relay lenses to position the focused beam at the BFP, is calibrated for incidence angle. Calibration depends on microscope characteristics and TIRF objective and is applicable to any interface or sample.

Indexed as

LensesEquipment Failure AnalysisLightMicroscopy, FluorescenceRefractometryReproducibility of ResultsScattering, RadiationSensitivity and Specificity

Identifiers

PMID23208218
PMCPMC3512109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.